JHEP Reports

Scope & Guideline

Fostering collaboration for groundbreaking health solutions.

Introduction

Explore the comprehensive scope of JHEP Reports through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JHEP Reports in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJHEP REP / JHEP Rep.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

JHEP Reports is focused on advancing the understanding and treatment of liver diseases. The journal emphasizes the integration of clinical findings with molecular and cellular mechanisms, aiming to bridge the gap between basic research and clinical application. It serves as a platform for innovative research in hepatology, particularly in areas related to liver cancer, hepatitis, liver transplantation, and metabolic liver diseases.
  1. Liver Disease Pathophysiology:
    Investigation into the underlying mechanisms and biological pathways involved in various liver diseases, including viral hepatitis, metabolic dysfunction-associated liver disease, and hepatocellular carcinoma.
  2. Clinical Management and Therapeutics:
    Studies addressing the clinical management of liver diseases, including novel therapeutic approaches, patient management strategies, and the impact of treatments on patient outcomes.
  3. Translational Research:
    Research that translates findings from basic science into clinical practice, focusing on biomarkers, therapeutic targets, and the efficacy of interventions in liver disease.
  4. Epidemiology and Public Health:
    Exploration of the epidemiological trends, risk factors, and public health implications associated with liver diseases, emphasizing the need for effective screening and prevention strategies.
  5. Innovative Diagnostic Techniques:
    Development and validation of new diagnostic tools and biomarkers for the early detection and monitoring of liver diseases, enhancing the precision of clinical assessments.
The landscape of liver disease research is evolving, with several themes emerging as particularly relevant in recent years. These trends reflect the ongoing advancements in understanding liver pathology and the development of innovative treatment strategies.
  1. Immunotherapy for Liver Cancer:
    There is a growing interest in exploring immunotherapeutic approaches for hepatocellular carcinoma, reflecting a broader trend in oncology towards harnessing the immune system to target cancer.
  2. Metabolic Liver Diseases:
    Research on metabolic dysfunction-associated fatty liver disease (MAFLD) is increasingly prominent, reflecting the rising global burden of obesity-related liver conditions and their complexities.
  3. Precision Medicine and Personalized Approaches:
    Emerging studies are increasingly focusing on personalized treatment plans based on genetic, metabolic, and immunological profiles, tailored to improve outcomes in liver disease patients.
  4. Microbiome and Liver Health:
    The exploration of the gut-liver axis and the role of the microbiome in liver disease pathogenesis and treatment is gaining traction, highlighting the interconnectedness of systems in health.
  5. Non-Invasive Biomarkers:
    There is a significant trend towards the development and validation of non-invasive biomarkers for liver disease diagnosis and monitoring, as researchers seek to reduce reliance on invasive procedures.

Declining or Waning

While JHEP Reports continues to publish a wide array of studies, certain themes appear to be losing prominence over recent years. This shift may reflect changing research priorities or advancements in treatment modalities that reduce the relevance of older topics.
  1. Traditional Imaging Techniques:
    There is a noticeable decline in studies focused solely on traditional imaging methods for liver disease diagnosis, as newer, more sophisticated techniques and biomarkers gain traction.
  2. Hepatitis C Management:
    Research specifically centered on hepatitis C management has waned, likely due to the successful implementation of direct-acting antiviral therapies that have transformed treatment approaches.
  3. Liver Disease Epidemiology in Stable Populations:
    There seems to be a decrease in studies that focus on static epidemiological data from stable populations, with a shift towards dynamic, real-time analyses that capture emerging trends and variations.
  4. Basic Science of Non-Alcoholic Fatty Liver Disease (NAFLD):
    Research detailing basic mechanisms of NAFLD appears to be declining as the focus shifts towards more clinically relevant studies that explore treatment outcomes and patient management.
  5. Palliative Care Approaches in Hepatology:
    The emphasis on palliative care strategies in liver disease management is decreasing, possibly as more effective curative and management options become available.

Similar Journals

Frontline Gastroenterology

Advancing the Frontiers of Gastroenterology
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

Korean Journal of Gastroenterology

Championing Breakthroughs in Gastroenterology
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

LIVER INTERNATIONAL

Advancing hepatology through cutting-edge research.
Publisher: WILEYISSN: 1478-3223Frequency: 12 issues/year

LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.

Clinical and Molecular Hepatology

Bridging clinical practice and molecular discoveries in liver health.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

World Journal of Hepatology

Innovating hepatology research for tomorrow's treatments.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

SEMINARS IN LIVER DISEASE

Elevating the discourse in liver disease management.
Publisher: THIEME MEDICAL PUBL INCISSN: 0272-8087Frequency: 4 issues/year

SEMINARS IN LIVER DISEASE is a premier journal dedicated to advancing the field of hepatology, published by THIEME MEDICAL PUBL INC. Established in 1981, it has become a respected resource within the academic community, providing high-quality peer-reviewed articles that cover a broad range of topics related to liver diseases. With an impressive impact factor and recognized as a Q1 journal in the hepatology category, it ranks 17th out of 82 journals in the field, placing it in the top 21% of its category according to Scopus rankings. Although it does not offer open access, the journal’s rigorous standards and extensive network ensure that it reaches a wide audience of clinicians, researchers, and students, fostering knowledge and innovation in liver disease management. The journal's objectives focus on disseminating critical insights and promoting informed discussions that can pave the way for future research and clinical advancements in hepatology.

JOURNAL OF HEPATOLOGY

Elevating Hepatology with Cutting-Edge Insights
Publisher: ELSEVIERISSN: 0168-8278Frequency: 12 issues/year

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.

DIGESTIVE AND LIVER DISEASE

Innovating research for better patient outcomes.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

WORLD JOURNAL OF GASTROENTEROLOGY

Empowering the global gastroenterology community.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1007-9327Frequency: 48 issues/year

WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Elevating standards in gastrointestinal and liver disease research.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.